Gain of HIF1 Activity and Loss of miRNA let-7d Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR Axis
Open Access
- 1 February 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (3), 594-605
- https://doi.org/10.1158/0008-5472.can-19-3560
Abstract
Early detection and adjuvant therapies have significantly improved survival of patients with breast cancer over the past three decades. In contrast, management of metastatic disease remains unresolved. Brain metastasis is a late complication frequently observed among patients with metastatic breast cancer, whose poor prognosis calls for novel and more effective therapies. Here, we report that active hypoxia inducible factor-1 (HIF1) signaling and loss of the miRNA let-7d concur to promote brain metastasis in a recently established model of spontaneous breast cancer metastasis from the primary site to the brain (4T1-BM2), and additionally in murine and human experimental models of breast cancer brain metastasis (D2A1-BM2 and MDA231-BrM2). Active HIF1 and let-7d loss upregulated expression of platelet-derived growth factor (PDGF) B/A in murine and human brain metastatic cells, respectively, while either individual silencing of HIF1α and PDGF-A/B or let-7d overexpression suppressed brain metastasis formation in the tested models. Let-7d silencing upregulated HIF1α expression and HIF1 activity, indicating a regulatory hierarchy of the system. The clinical relevance of the identified targets was supported by human gene expression data analyses. Treatment of mice with nilotinib, a kinase inhibitor impinging on PDGF receptor (PDGFR) signaling, prevented formation of spontaneous brain metastases in the 4T1-BM2 model and reduced growth of established brain metastases in mouse and human models. These results identify active HIF1 signaling and let-7d loss as coordinated events promoting breast cancer brain metastasis through increased expression of PDGF-A/B. Moreover, they identify PDGFR inhibition as a potentially actionable therapeutic strategy for patients with brain metastatis. These findings show that loss of miRNA let-7d and active HIF1 signaling promotes breast cancer brain metastasis via PDGF and that pharmacologic inhibition of PDGFR suppresses brain metastasis, suggesting novel therapeutic opportunities.Other Versions
Funding Information
- Swiss National Science Foundation (PDFMP3_137079, 31003A_159824, 31003A_179248)
- Swiss Cancer League (KFS-2814-08-2011, KFS-3513-08-2014, KFS 4400-02-2018)
This publication has 49 references indexed in Scilit:
- Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2012
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapyTrends in Pharmacological Sciences, 2012
- Nilotinib: A Novel, Selective Tyrosine Kinase InhibitorSeminars in Oncology, 2011
- Modeling metastasis in the mouseCurrent Opinion in Pharmacology, 2010
- Hypoxia-inducible Factor-1 Activation in Nonhypoxic Conditions: The Essential Role of Mitochondrial-derived Reactive Oxygen SpeciesMolecular Biology of the Cell, 2010
- Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signalingMolecular Neurodegeneration, 2010
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- Lin28 Mediates the Terminal Uridylation of let-7 Precursor MicroRNAMolecular Cell, 2008
- Autocrine PDGFR signaling promotes mammary cancer metastasisJCI Insight, 2006